SCHEMBL10286304

SCHEMBL10286304

OC1CCCc2c(Cl)cc(Oc3ccccc3)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.49
BCHE P06276 5/20 0.38
HPGD P15428 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPK1 P28482 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 2/20 0.33
CYP1A2 P05177 2/20 0.33
MAPT P10636 2/20 0.33
CYP2C9 P11712 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CYP2C19 P33261 1/20 0.33
ATM Q13315 1/20 0.33
SLC2A1 P11166 1/20 0.33
TSHR P16473 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NR3C1 P04150 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10286365 0.86 ACHE (0.47) ACHEBCHEHPGDALDH1A1KDM4E
SCHEMBL10286330 0.80 ACHE (0.42) ACHEBCHE
SCHEMBL527120 0.77 ACHE (0.46) ACHEBCHEHPGDMAPK1MEN1
SCHEMBL10286340 0.76 ACHE (0.39) ACHEALDH1A1KDM4EMEN1MAPT
SCHEMBL10286376 0.76 ACHE (0.41) ACHEALDH1A1CYP1A2CYP2C9TSHR
SCHEMBL10287390 0.74 ACHE (0.47) ACHEALDH1A1KDM4EHSD17B10TDP1
SCHEMBL10286356 0.73 ACHE (0.42) ACHEBCHEHPGDMAPK1MEN1
SCHEMBL10286528 0.73 ACHE (0.64) ACHEBCHEALDH1A1KDM4ECYP1A2
SCHEMBL526851 0.72 ACHE (0.44) ACHEALDH1A1KDM4EHSD17B10MAPK1
SCHEMBL10286483 0.71 BCHE (0.42) ACHEBCHEHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
WO-2012001040-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES MSR1, DDT, MPO ACHE 660/4885BCHE 2014/4885HPGD 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.